The involvement of HPV in oropharyngeal neoplasms has shown a favorable treatment response and a good prognosis with the expression of p16, which may be considered a marker for the identification of HPV(+) neoplasms in the head and neck region [18,19]. Here, CDKN2A is linked to neoplasm.